The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced significant uncertainty . Investors are now facing the effect of lower-